Literature DB >> 3072926

Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins.

N A Curtis1, R L Eisenstadt, S J East, R J Cornford, L A Walker, A J White.   

Abstract

Selected aminothiazolyl-oxime cephalosporin congeners substituted at C-3' with a catechol moiety were used to probe the basis of the enhanced antibacterial activity against Escherichia coli K-12 often associated with chemical modifications of this type. Evidence is presented for a tonB-dependent illicit transport of the compounds across the outer membrane of E. coli K-12, the process involving jointly and specifically the Fiu and Cir iron-regulated outer membrane proteins. Thus, both tonB and fiu cir mutants showed a comparably reduced susceptibility to the probe compounds, whereas mutants singularly lacking any one of the six iron-regulated outer membrane proteins (Fiu, FepA, FecA, FhuA, FhuE, and Cir) or lacking any combination of any two of these proteins (except Fiu plus Cir) did not show this resistance. Mutants devoid of all six iron-regulated outer membrane proteins were no more resistant to the probe compounds than fiu cir or tonB strains. In addition to the latter genes, the products of the exbB and possibly the exbC loci were necessary for maximal antibacterial potency. A dependence of antibacterial activity on the level of expression of the uptake system components was noted. Comparison of penicillin-binding protein target affinity with antibacterial activity suggested a possible periplasmic accumulation of active compounds by E. coli K-12. Free vicinal hydroxyl groups of the catechol residue were a primary chemical requirement for recognition by the uptake pathway and thus for high antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072926      PMCID: PMC176037          DOI: 10.1128/AAC.32.12.1879

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Characterization of group B colicin-resistant mutants of Escherichia coli K-12: colicin resistance and the role of enterochelin.

Authors:  A P Pugsley; P Reeves
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

2.  Novel iron uptake system specified by ColV plasmids: an important component in the virulence of invasive strains of Escherichia coli.

Authors:  P H Williams
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Iron uptake in colicin B-resistant mutants of Escherichia coli K-12.

Authors:  A P Pugsley; P Reeves
Journal:  J Bacteriol       Date:  1976-06       Impact factor: 3.490

4.  Escherichia coli pleiotropic mutant that reduces amounts of several periplasmic and outer membrane proteins.

Authors:  B L Wanner; A Sarthy; J Beckwith
Journal:  J Bacteriol       Date:  1979-10       Impact factor: 3.490

Review 5.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

6.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

7.  Functional interaction of the tonA/tonB receptor system in Escherichia coli.

Authors:  K Hantke; V Braun
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

8.  Influence of chromosome structure on the frequency of tonB trp deletions in Escherichia coli.

Authors:  M B Coukell; C Yanofsky
Journal:  J Bacteriol       Date:  1971-03       Impact factor: 3.490

9.  Excretion of enterochelin by exbA and exbB mutants of Escherichia coli.

Authors:  S K Guterman; L Dann
Journal:  J Bacteriol       Date:  1973-06       Impact factor: 3.490

10.  Lactose genes fused to exogenous promoters in one step using a Mu-lac bacteriophage: in vivo probe for transcriptional control sequences.

Authors:  M J Casadaban; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

View more
  54 in total

1.  Differences in sensitivity to PA-1806 among iron transport mutants of Pseudomonas aeruginosa compared to Escherichia coli.

Authors:  W R Schwan; L Barker; L L Brody
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  TonB interacts with nonreceptor proteins in the outer membrane of Escherichia coli.

Authors:  Penelope I Higgs; Tracy E Letain; Kelley K Merriam; Neal S Burke; HaJeung Park; ChulHee Kang; Kathleen Postle
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

3.  In vitro antibacterial activity of KP-736, a new cephem antibiotic.

Authors:  T Maejima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

5.  In vitro activity of a catechol-substituted cephalosporin, GR69153.

Authors:  R Wise; J M Andrews; J P Ashby; D Thornber
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 6.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

7.  Disk diffusion susceptibility test interpretive criteria for GR69153, a new catechol-substituted cephalosporin.

Authors:  R N Jones; M E Erwin
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.

Authors:  M E Erwin; R N Jones; M S Barrett; B M Briggs; D M Johnson
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 9.  Transport of iron across the outer membrane.

Authors:  V Braun; K Günter; K Hantke
Journal:  Biol Met       Date:  1991

10.  In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

Authors:  S Nakagawa; M Sanada; K Matsuda; T Hashizume; Y Asahi; R Ushijima; N Ohtake; N Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.